z-logo
open-access-imgOpen Access
Delivering precision antimicrobial therapy through closed-loop control systems
Author(s) -
Timothy M. Rawson,
Dermot O’Hare,
Pau Herrero,
Sanjiv Sharma,
Luke Moore,
Eoghan de Barra,
Jason A. Roberts,
Anthony Gordon,
William Hope,
Pantelis Georgiou,
Anthony E. G. Cass,
Alison Holmes
Publication year - 2017
Publication title -
journal of antimicrobial chemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.124
H-Index - 194
eISSN - 1460-2091
pISSN - 0305-7453
DOI - 10.1093/jac/dkx458
Subject(s) - antimicrobial , antimicrobial drug , closed loop , intensive care medicine , therapeutic drug monitoring , antibiotic resistance , medicine , drug resistance , risk analysis (engineering) , biochemical engineering , drug , biomedical engineering , computer science , medical physics , pharmacology , antibiotics , control engineering , engineering , biology , microbiology and biotechnology
Sub-optimal exposure to antimicrobial therapy is associated with poor patient outcomes and the development of antimicrobial resistance. Mechanisms for optimizing the concentration of a drug within the individual patient are under development. However, several barriers remain in realizing true individualization of therapy. These include problems with plasma drug sampling, availability of appropriate assays, and current mechanisms for dose adjustment. Biosensor technology offers a means of providing real-time monitoring of antimicrobials in a minimally invasive fashion. We report the potential for using microneedle biosensor technology as part of closed-loop control systems for the optimization of antimicrobial therapy in individual patients.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom